LANGER DENNIS
Insider CIK 1274225 · PTX Director · DRNA Director · QNRX Director · BTX Director · DCTH Director · MYGN Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| QNRX Quoin Pharmaceuticals, Ltd | A Award | 2026-08-27 | 2026-08-28 | 34,534 | $5.15 | $177.9K | 56,243 | SEC↗ |
| QNRX Quoin Pharmaceuticals, Ltd | A Award | 2026-08-27 | 2026-08-28 | 34,534 | $5.15 | $177.9K | 56,243 | SEC↗ |
| QNRX Quoin Pharmaceuticals, Ltd | A Award deriv | 2026-02-04 | 2026-02-06 | 21,709 | — | $0 | 21,709 | SEC↗ |
| QNRX Quoin Pharmaceuticals, Ltd | P Buy deriv | 2025-10-14 | 2025-10-15 | 15,152 | — | $0 | 15,152 | SEC↗ |
| QNRX Quoin Pharmaceuticals, Ltd | P Buy deriv | 2025-10-14 | 2025-10-15 | 15,152 | — | $0 | 15,152 | SEC↗ |
| QNRX Quoin Pharmaceuticals, Ltd | P Buy deriv | 2025-10-14 | 2025-10-15 | 15,152 | — | $0 | 15,152 | SEC↗ |
| QNRX Quoin Pharmaceuticals, Ltd | P Buy deriv | 2025-10-14 | 2025-10-15 | 15,152 | — | $0 | 15,152 | SEC↗ |
| QNRX Quoin Pharmaceuticals, Ltd | P Buy | 2025-10-14 | 2025-10-15 | 15,152 | $8.49 | $128.6K | 15,153 | SEC↗ |
| QNRX Quoin Pharmaceuticals, Ltd | A Award deriv | 2025-08-21 | 2025-08-25 | 13,682 | — | $0 | 13,682 | SEC↗ |
| QNRX Quoin Pharmaceuticals, Ltd | A Award deriv | 2025-05-29 | 2025-06-02 | 7,760 | — | $0 | 7,760 | SEC↗ |
| QNRX Quoin Pharmaceuticals, Ltd | A Award deriv | 2024-12-09 | 2024-12-10 | 50,714 | — | $0 | 50,714 | SEC↗ |
| QNRX Quoin Pharmaceuticals, Ltd | S Sale | 2024-06-07 | 2024-06-10 | 297 | $0.73 | $217 | 53 | SEC↗ |
| QNRX Quoin Pharmaceuticals, Ltd | A Award deriv | 2023-10-26 | 2023-10-30 | 7,652 | — | $0 | 7,652 | SEC↗ |
| MYGN MYRIAD GENETICS INC | A Award | 2022-06-02 | 2022-06-03 | 17,275 | — | $0 | 106,802 | SEC↗ |
| BTX Brooklyn ImmunoTherapeutic | A Award deriv | 2021-12-08 | 2021-12-10 | 67,000 | — | $0 | 67,000 | SEC↗ |
| MYGN MYRIAD GENETICS INC | M Exercise deriv | 2021-08-03 | 2021-08-05 | 30,000 | — | $0 | 0 | SEC↗ |
| MYGN MYRIAD GENETICS INC | M Exercise | 2021-08-03 | 2021-08-05 | 30,000 | $25.39 | $761.7K | 119,527 | SEC↗ |
| MYGN MYRIAD GENETICS INC | S Sale | 2021-08-03 | 2021-08-05 | 30,000 | $34.75 | $1.04M | 89,527 | SEC↗ |
| MYGN MYRIAD GENETICS INC | A Award | 2021-06-03 | 2021-06-04 | 12,848 | — | $0 | 89,527 | SEC↗ |
| MYGN MYRIAD GENETICS INC | A Award | 2020-12-04 | 2020-12-07 | 15,889 | — | $0 | 76,679 | SEC↗ |
| MYGN MYRIAD GENETICS INC | A Award | 2019-12-05 | 2019-12-06 | 11,687 | — | $0 | 60,790 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2019-06-20 | 2019-06-21 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MYGN MYRIAD GENETICS INC | A Award | 2018-11-29 | 2018-11-30 | 9,360 | — | $0 | 49,103 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2018-08-15 | 2018-08-17 | 14,531 | $16.00 | $232.5K | 29,064 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2018-08-15 | 2018-08-17 | 23,810 | $16.00 | $381.0K | 47,978 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2018-06-21 | 2018-06-25 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MYGN MYRIAD GENETICS INC | M Exercise deriv | 2018-06-08 | 2018-06-08 | 13,664 | — | $0 | 0 | SEC↗ |
| MYGN MYRIAD GENETICS INC | S Sale | 2018-06-08 | 2018-06-08 | 13,664 | $39.35 | $537.7K | 39,743 | SEC↗ |
| MYGN MYRIAD GENETICS INC | M Exercise | 2018-06-08 | 2018-06-08 | 13,664 | $21.29 | $290.9K | 53,407 | SEC↗ |
| MYGN MYRIAD GENETICS INC | M Exercise deriv | 2018-06-07 | 2018-06-08 | 3,096 | — | $0 | 13,664 | SEC↗ |
| MYGN MYRIAD GENETICS INC | M Exercise | 2018-06-07 | 2018-06-08 | 3,096 | $21.29 | $65.9K | 42,839 | SEC↗ |
| MYGN MYRIAD GENETICS INC | S Sale | 2018-06-07 | 2018-06-08 | 3,096 | $39.35 | $121.8K | 39,743 | SEC↗ |
| MYGN MYRIAD GENETICS INC | M Exercise deriv | 2018-06-06 | 2018-06-08 | 3,609 | — | $0 | 16,760 | SEC↗ |
| MYGN MYRIAD GENETICS INC | M Exercise | 2018-06-06 | 2018-06-08 | 3,609 | $21.29 | $76.8K | 43,352 | SEC↗ |
| MYGN MYRIAD GENETICS INC | S Sale | 2018-06-06 | 2018-06-08 | 3,609 | $39.37 | $142.1K | 39,743 | SEC↗ |
| MYGN MYRIAD GENETICS INC | M Exercise deriv | 2018-06-05 | 2018-06-05 | 1,227 | — | $0 | 20,369 | SEC↗ |
| MYGN MYRIAD GENETICS INC | M Exercise | 2018-06-05 | 2018-06-05 | 1,227 | $21.29 | $26.1K | 40,970 | SEC↗ |
| MYGN MYRIAD GENETICS INC | S Sale | 2018-06-05 | 2018-06-05 | 1,227 | $39.90 | $49.0K | 39,743 | SEC↗ |
| MYGN MYRIAD GENETICS INC | M Exercise deriv | 2018-06-04 | 2018-06-05 | 10,000 | — | $0 | 0 | SEC↗ |
| MYGN MYRIAD GENETICS INC | M Exercise deriv | 2018-06-04 | 2018-06-05 | 8,404 | — | $0 | 21,596 | SEC↗ |
| MYGN MYRIAD GENETICS INC | M Exercise | 2018-06-04 | 2018-06-05 | 10,000 | $24.39 | $243.9K | 49,743 | SEC↗ |
| MYGN MYRIAD GENETICS INC | S Sale | 2018-06-04 | 2018-06-05 | 10,000 | $39.90 | $399.0K | 39,743 | SEC↗ |
| MYGN MYRIAD GENETICS INC | M Exercise | 2018-06-04 | 2018-06-05 | 8,404 | $21.29 | $178.9K | 48,147 | SEC↗ |
| MYGN MYRIAD GENETICS INC | S Sale | 2018-06-04 | 2018-06-05 | 8,404 | $39.90 | $335.3K | 39,743 | SEC↗ |
| MYGN MYRIAD GENETICS INC | M Exercise deriv | 2018-06-01 | 2018-06-05 | 30,000 | — | $0 | 0 | SEC↗ |
| MYGN MYRIAD GENETICS INC | S Sale | 2018-06-01 | 2018-06-05 | 30,000 | $38.90 | $1.17M | 39,743 | SEC↗ |
| MYGN MYRIAD GENETICS INC | M Exercise | 2018-06-01 | 2018-06-05 | 30,000 | $24.40 | $732.0K | 69,743 | SEC↗ |
| MYGN MYRIAD GENETICS INC | M Exercise deriv | 2018-05-30 | 2018-06-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| MYGN MYRIAD GENETICS INC | M Exercise | 2018-05-30 | 2018-06-01 | 10,000 | $24.39 | $243.9K | 49,743 | SEC↗ |
| MYGN MYRIAD GENETICS INC | S Sale | 2018-05-30 | 2018-06-01 | 10,000 | $37.92 | $379.2K | 39,743 | SEC↗ |
| PTX PERNIX THERAPEUTICS HOLDIN | A Award deriv | 2018-05-22 | 2018-05-23 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MYGN MYRIAD GENETICS INC | M Exercise deriv | 2018-05-21 | 2018-05-21 | 10,000 | $35.90 | $359.0K | 20,000 | SEC↗ |
| MYGN MYRIAD GENETICS INC | S Sale | 2018-05-21 | 2018-05-21 | 10,000 | $35.90 | $359.0K | 39,743 | SEC↗ |
| MYGN MYRIAD GENETICS INC | M Exercise | 2018-05-21 | 2018-05-21 | 10,000 | $24.39 | $243.9K | 49,743 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise deriv | 2018-01-26 | 2018-01-30 | 360 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise | 2018-01-26 | 2018-01-30 | 360 | $3.42 | $1.2K | 71,788 | SEC↗ |
| MYGN MYRIAD GENETICS INC | A Award | 2017-11-30 | 2017-11-30 | 7,219 | — | $0 | 39,743 | SEC↗ |
| PTX PERNIX THERAPEUTICS HOLDIN | A Award deriv | 2017-11-15 | 2017-11-17 | 50,000 | — | $0 | 50,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2017-07-18 | 2017-07-20 | 25,000 | — | $0 | 25,000 | SEC↗ |
| MYGN MYRIAD GENETICS INC | A Award | 2016-12-01 | 2016-12-01 | 15,024 | — | $0 | 32,524 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | S Sale | 2016-11-16 | 2016-11-17 | 23,766 | $3.52 | $83.7K | 71,428 | SEC↗ |
| PTX PERNIX THERAPEUTICS HOLDIN | A Award deriv | 2016-11-04 | 2016-11-08 | 4,000 | — | $0 | 4,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2016-06-14 | 2016-06-15 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise deriv | 2016-02-03 | 2016-02-05 | 34,722 | — | $0 | 6,945 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise | 2016-02-03 | 2016-02-05 | 34,722 | $3.42 | $118.7K | 43,595 | SEC↗ |
| MYGN MYRIAD GENETICS INC | A Award | 2015-12-03 | 2015-12-07 | 7,500 | — | $0 | 17,500 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2015-06-25 | 2015-06-26 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DCTH DELCATH SYSTEMS, INC. | A Award deriv | 2015-06-10 | 2015-06-12 | 30,000 | — | $0 | 30,000 | SEC↗ |
| DCTH DELCATH SYSTEMS, INC. | A Award | 2015-06-10 | 2015-06-12 | 20,000 | — | $0 | 20,000 | SEC↗ |
| DCTH DELCATH SYSTEMS, INC. | A Award deriv | 2014-12-11 | 2014-12-15 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MYGN MYRIAD GENETICS INC | A Award | 2014-12-04 | 2014-12-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2014-06-18 | 2014-06-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2014-04-16 | 2014-04-18 | 25,000 | — | $0 | 25,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-04-21 | 8,586 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-04-21 | 15,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-04-21 | 71,428 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion | 2014-02-04 | 2014-04-21 | 95,014 | — | $0 | 95,194 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-04 | 10,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-04 | 71,428 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-02-04 | 2014-02-04 | 8,586 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion | 2014-02-04 | 2014-02-04 | 90,014 | — | $0 | 90,194 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-01-29 | 2014-02-20 | 10,000 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-01-29 | 2014-02-20 | 8,586 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion deriv | 2014-01-29 | 2014-02-20 | 71,428 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | C Conversion | 2014-01-29 | 2014-02-20 | 90,014 | — | $0 | 90,014 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise deriv | 2014-01-27 | 2014-02-20 | 8,333 | — | $0 | 41,667 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise deriv | 2014-01-27 | 2014-02-20 | 540 | — | $0 | 0 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | M Exercise | 2014-01-27 | 2014-02-20 | 8,873 | $3.42 | $30.3K | 8,873 | SEC↗ |
| MYGN MYRIAD GENETICS INC | A Award deriv | 2013-12-05 | 2013-12-06 | 30,000 | — | $0 | 30,000 | SEC↗ |
| DRNA Dicerna Pharmaceuticals In | A Award deriv | 2013-09-24 | 2014-02-20 | 50,000 | — | $0 | 50,000 | SEC↗ |
| MYGN MYRIAD GENETICS INC | A Award deriv | 2012-12-05 | 2012-12-05 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MYGN MYRIAD GENETICS INC | M Exercise deriv | 2012-11-30 | 2012-12-03 | 30,000 | — | $0 | 0 | SEC↗ |
| MYGN MYRIAD GENETICS INC | M Exercise deriv | 2012-11-30 | 2012-12-03 | 15,000 | — | $0 | 0 | SEC↗ |
| MYGN MYRIAD GENETICS INC | S Sale | 2012-11-30 | 2012-12-03 | 30,000 | $29.92 | $897.6K | 0 | SEC↗ |
| MYGN MYRIAD GENETICS INC | M Exercise | 2012-11-30 | 2012-12-03 | 30,000 | $21.66 | $649.8K | 30,000 | SEC↗ |
| MYGN MYRIAD GENETICS INC | S Sale | 2012-11-30 | 2012-12-03 | 15,000 | $29.89 | $448.4K | 0 | SEC↗ |
| MYGN MYRIAD GENETICS INC | M Exercise | 2012-11-30 | 2012-12-03 | 15,000 | $16.46 | $246.9K | 15,000 | SEC↗ |
| MYGN MYRIAD GENETICS INC | M Exercise deriv | 2012-11-29 | 2012-12-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| MYGN MYRIAD GENETICS INC | M Exercise deriv | 2012-11-29 | 2012-12-03 | 10,000 | — | $0 | 0 | SEC↗ |
| MYGN MYRIAD GENETICS INC | M Exercise | 2012-11-29 | 2012-12-03 | 15,000 | $16.46 | $246.9K | 15,000 | SEC↗ |
| MYGN MYRIAD GENETICS INC | S Sale | 2012-11-29 | 2012-12-03 | 10,000 | $29.82 | $298.2K | 0 | SEC↗ |
| MYGN MYRIAD GENETICS INC | M Exercise | 2012-11-29 | 2012-12-03 | 10,000 | $10.60 | $106.0K | 10,000 | SEC↗ |
| MYGN MYRIAD GENETICS INC | S Sale | 2012-11-29 | 2012-12-03 | 15,000 | $29.82 | $447.3K | 0 | SEC↗ |